EMEA-001687-PIP01-14-M06
Table of contents
Key facts
Invented name |
Rukobia
|
Active substance |
fostemsavir (tromethamine)
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0067/2022
|
PIP number |
EMEA-001687-PIP01-14-M06
|
Pharmaceutical form(s) |
Prolonged-release tablet
|
Condition(s) / indication(s) |
Treatment of human immunodeficiency virus (HIV-1) infection
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
ViiV Healthcare UK Ltd
+44 (0)7467 443192 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|